Midgard Science

OXB

Durham, NC, United Statesoxb.comFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

OXB is a viral vector CDMO serving cell and gene therapy developers from pre-clinical through commercial stages. It operates facilities in the UK, US, and France and supports clients worldwide with development, GMP manufacturing, analytics, quality, and regulatory services.

Services

  • Process development

    Develops viral vector processes across upstream and downstream stages to support scale-up and GMP readiness.

  • GMP manufacturing

    Manufactures viral vectors under GMP from clinical through commercial supply.

  • Analytical methods

    Develops and performs analytical testing to support vector characterization, release, and regulatory filings.

  • Regulatory support

    Supports IND, MAA, and other regulatory submissions through to commercial launch.

  • Quality services

    Provides integrated quality oversight across development, manufacturing, testing, and supply.

  • AAV manufacturing

    Offers AAV development and manufacturing using the inAAVate™ platform.

  • Lentiviral vector manufacturing

    Offers lentiviral vector development and manufacturing using the LentiVector™ platform.

  • Adenovirus manufacturing

    Provides custom adenovirus development, manufacturing, and tech transfer-in.

2 more services
  • Tech transfer
  • Fill-finish
Turnaround
  • AAV to GMP manufacture in as little as 7 months
  • Lentiviral vectors to GMP manufacture in as little as 9 months
  • Can accelerate timeline to GMP manufacturing by up to nine months

Capabilities

Assays and studies
  • AAV
  • Lentivirus
  • Process development
  • Analytical development
  • Fill-finish
  • Potency
4 more
  • Purity
  • Safety
  • Analytical assays
  • Regulatory analytical qualification
Scale and capacity
  • 18 GMP suites across geographies
  • 200L
  • 500L
  • 1,000L
  • 2,000L
  • 500L scale
3 more
  • 1,000L scale
  • 500L AAV scale
  • 200L lentiviral scale
Therapeutic areas
  • Cell therapy
  • Gene therapy
  • In vivo gene therapies

Modalities and species

Modalities
  • Viral vector
  • Cell therapy
Species and models
  • Chimpanzee adenovirus (ChAdOx1)
  • Wild type AAVs

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: development, manufacturing and commercial supply

Company

Type
CDMO
Founded
1995
Size
501-1000 employees

Locations

Office
1 Patriots Park Bedford MA 01730
Sites
Oxford, United Kingdom · Lyon, France · Strasbourg, France · Dublin, Ireland
Serves
UK, US, Europe, global

Public records

Biocom California CRO directory
AAV, CDMO, contract manufacturing, Lenti, Viral Vector source

Similar labs